You are here

AstraZeneca

Lynparza boosts long-term survival in early breast cancer

Pharmaphorum

Thu, 12/12/24 - 11:29 am

ASH 2024: AstraZeneca set to take a BiTE out of follicular lymphoma market

Clinical Trials Arena

Mon, 12/9/24 - 11:12 am

follicular lymphoma

ASH: AstraZeneca proposes fixed-duration Calquence combos in chronic lymphocytic leukemia

Fierce Pharma

Sun, 12/8/24 - 09:53 pm

chronic lymphocytic leukemia

AstraZeneca, Daiichi share data behind Dato-DXd do-over amid 2nd bid for lung cancer approval

Fierce Biotech

Fri, 12/6/24 - 09:51 am

FDA clears AZ's Imfinzi for aggressive lung cancer

Pharmaphorum

Thu, 12/5/24 - 11:10 am

small cell lung cancer

Relief for AZ as Truqap hits the spot in prostate cancer

Pharmaphorum

Mon, 11/25/24 - 09:23 am

clinical trials

FDA experts lukewarm on AZ's anticoagulant antidote Andexxa

Pharmaphorum

Fri, 11/22/24 - 11:07 am

anticoagulant reversal

England's NICE turns down cancer drug Enhertu—again—amid pricing stalemate with AZ, Daiichi Sankyo

Fierce Pharma

Tue, 11/19/24 - 07:14 pm

Merck, AstraZeneca report positive data for Koselugo in adults

MSN/Seeking Alpha

Tue, 11/12/24 - 08:49 pm

clinical trials

neurofibromatosis

AstraZeneca, Daiichi withdraw lung cancer approval application for Enhertu follow-up and try again

Fierce Biotech

Tue, 11/12/24 - 08:44 pm

AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investigations 'Very Seriously'

Yahoo/Benzinga

Tue, 11/12/24 - 11:07 am

Chasing $80bn sales target, AZ unveils $3.5bn US investment

Pharmaphorum

Tue, 11/12/24 - 09:48 am

drug manufacturing

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial

Clinical Trials Arena

Fri, 11/8/24 - 11:34 am

clinical trials

chronic rhinosinusitis with nasal polyps

Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in

Pharma Voice

Thu, 11/7/24 - 11:12 am

Vertex Pharmacuticals

Alpine Immune Sciences

Mariana Oncology

Fusion Pharmaceuticals

Longboard Pharmaceuticals

Aliada Therapeutics

AstraZeneca's China chief in custody, believes unrelated to insurance probe

MSN/Reuters

Wed, 11/6/24 - 08:13 pm

AstraZeneca stock tanks over fears of expanding China fraud probe

Fierce Pharma

Tue, 11/5/24 - 06:20 pm

AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial

MSN/Reuters

Mon, 11/4/24 - 11:25 am

clinical trials

Pharmas ask appeals court to reconsider IRA lawsuits

Pharmaphorum

Mon, 11/4/24 - 11:08 am

Inflation Reduction Act

Bristol Myers Squibb

AstraZeneca's China president faces 'ongoing investigation' by authorities in the country

Fierce Pharma

Wed, 10/30/24 - 11:43 am

How AZ’s respiratory wins are ramping up for a bigger prize in COPD

Pharma Voice

Tue, 10/29/24 - 10:57 am

Pages